Please login to the form below

Not currently logged in
Email:
Password:

Avril Lee joins Burson-Marsteller in global role

Based in the UK, she joins the firm as its deputy global healthcare practice chair

Avril LeeBurson-Marsteller (BM) has strengthened its healthcare capabilities with the addition of Avril Lee, who joins the global PR and coms agency as  deputy global healthcare practice chair.

Based in the UK, Lee - who moves to the firm on February 19 - will partner with global healthcare practice chair Helene Ellison to expand the firm’s healthcare representation.

Commenting on the new appointment, BM’s worldwide chair and chief executive officer Don Baer said: “Avril is going to make a big contribution to helping us serve the most important healthcare clients in key markets around the world.”

For the past two years Lee has been serving as managing director of MSLGroup’s UK and EMEA Health Practices, overseeing business that included portfolio communications for Allergan.

Prior to that, she spent two years with Luther Pendragon as a director leading the AbbVie Humira business, and serving on the agency's senior leadership team, and before that she spent a decade with Ketchum London.

Lee said: “I am excited to get started expanding Burson-Marsteller’s healthcare expertise around the globe.”

12th February 2018

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...

Infographics